Its latest move reflects a powerful confluence of developments — geopolitical, commercial, and operational — that have come together in rapid succession to fundamentally reframe the company’s near-term growth trajectory.

The screen turned defensive this week. After last week’s enterprise software dominance, the breakouts are clustered in healthcare and consumer names instead — four healthcare, three consumer, one software. Seven of the 10 are still inside their patterns. The trade is mostly anticipation.

The fundamental story underneath the chart is just as strong.

We’re targeting 12%-21% potential upside.

It’s coiling in a textbook symmetrical triangle on the daily chart while holding above a key resistance-turned-support level on the weekly — a dual-timeframe technical setup that historically signals the start of a sustained move higher.

Plus, our NOW trade is up 30% in just two weeks, our IBM trade just hit our second price target for a 26% return in under two weeks, and our SMCI trade is up 32% in under one month.

Plus, our recommended IBM trade is already up 17% from our buy level in just over a week.